Adding ovarian suppression to tamoxifen for premenopausal breast cancer: A randomized phase III trial

  • Hyun Ah Kim
  • , Jong Won Lee
  • , Seok Jin Nam
  • , Byeong Woo Park
  • , Seock Ah Im
  • , Eun Sook Lee
  • , Yong Sik Jung
  • , Jung Han Yoon
  • , Sung Soo Kang
  • , Soo Jung Lee
  • , Kyong Hwa Park
  • , Joon Jeong
  • , Se Heon Cho
  • , Sung Yong Kim
  • , Lee Su Kim
  • , Byung In Moon
  • , Min Hyuk Lee
  • , Tae Hyun Kim
  • , Chanheun Park
  • , Sung Hoo Jung
    • Geumhee Gwak, Jeryong Kim, Sun Hee Kang, Young Woo Jin, Hee Jeong Kim, Se Hwan Han, Wonshik Han, Min Hee Hur, Woo Chul Noh*
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

78 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adding ovarian suppression to tamoxifen for premenopausal breast cancer: A randomized phase III trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science